Preparation of transfersomes encapsulating sildenafil aimed for transdermal drug delivery: Plackett-Burman design and characterization

Journal of Liposome Research

Volumn 25, Issue 1, 2015, Pages 1-10

  Ahmed, Tarek A ^a  

^a Al Azhar University   (Egypt)

Author keywords

Entrapment efficiency; Plackett Burman design; Sildenafil citrate; Transfersomes

Indexed keywords

SILDENAFIL; SURFACTANT;

ARTICLE; DRUG DESIGN; DRUG FORMULATION; DRUG SYNTHESIS; ENCAPSULATION; HYDRATION; HYDROPHILICITY; IN VITRO STUDY; LIPOPHILICITY; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TEMPERATURE; ZETA POTENTIAL;

EID: 84964203156     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2014.950276     Document Type: Article

References (58)

1. Abdelwahed W, Degobert G, Stainmesse S, Fessi H. (2006). Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev 58:1688-713.
2. Antoniu SA. (2006). Sildenafil citrate for the treatment of pulmonary arterial hypertension. Expert Opin Pharmacother 7:825-8.
3. Arica B, Ozer AY, Ercan MT, Hincal AA. (1995). Characterization, in vitro and in vivo studies on primaquine diphosphate liposomes. J Microencapsul 12:469-85.
4. Carson CC. (2003). 3rd Sildenafil: a 4-year update in the treatment of 20 million erectile dysfunction patients. Curr Urol Rep 4:488-96.
5. Cevc G, Blume G, Schätzlein A. (1997). Transferosomes-mediated transepidermal delivery improves the regiospecificity and biological activity of corticosteroids in vivo. J Control Rel 45:211-26.
6. Cevc G, Blume G. (2001). New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, transferosomes. Biochim Biophys Acta 1514:191-205.
7. Cevc G, Schatzlein A, Blume G. (1995). Transdermal drug carriers: basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides. J Control Rel 36:3-16.
8. Cevc G, ed. (1993). Phospholipids handbook. New York: Marcel Dekker, 939-56.
9. Cevc G. (2003). Transdermal drug delivery of insulin with ultradeformable carriers. Clin Pharmacokinet 42:461-74.
10. Chandra A, Sharma PK. (2008). Proniosome based drug delivery system of piroxicam. African J Pharm Pharmacol 2:184-90.
11. Deveci S, Peskircioglu L, Aygun C, et al. (2004). Sublingual sildenafil in the treatment of erectile dysfunction: faster onset of action with less dose. Int J Urol 11:989-92.
12. El Zaafarany GM, Awad GAS, Holayel SM, Mortada ND. (2010). Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm 397:164-72.
13. El-Laithy HM, Shoukry O, Mahran LG. (2011). Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. Eur J Pharm Biopharm 77:43-55.
14. El-Malah Y, Nazzal S. (2006). Hydrophilic matrices: application of Placktt-Burman screening design to model the effect of polyoxcarbopol blends on drug release. Int J Pharm 309:163-70.
15. Elnaggar YS, El-Massik MA, Abdallah OY. (2011). Fabrication, appraisal, and transdermal permeation of sildenafil citrate loaded nanostructured lipid carriers versus solid lipid nanoparticles. Int J Nanomedicine 6:3195-205.
16. Elshafeey AH, Bendas ER, Mohamed OH. (2009). Intranasal microemulsion of sildenafil citrate: in vitro evaluation and in vivo pharmacokinetic study in rabbits. AAPS PharmSciTech 10:361-7.
17. Essa EA, Bonner MC, Barry BW. (2004). Electrically assisted skin delivery of liposomal estradiol: phospholipid as damage retardant. J Control Rel 95:535-46.
18. Galie N, Ghofrani HA, Torbicki A, et al. (2005). Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 353:2148-57.
19. Ghasemian E, Vatanara A, Najafabadi AR, et al. (2013). Preparation, characterization and optimization of sildenafil citrate loaded PLGA nanoparticles by statistical factorial design. DARU 21:68.
20. Handjani-Vila RM. (1990). Non-ionic vesicles as drug delivery systems. Fifth International Pharmaceutical Technology Symposium September; 1990; Ankara.
21. Hathout RM, Mansour S, Mortada ND, Guinedi AS. (2007). Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS PharmSciTech 8:1.
22. Hofer C, Hartung R, Gobel R, et al. (2000). New ultradeformable drug carriers for potential transdermal application of interleukin-2 and interferon-alpha: theoretic and practical aspects. World J Surg 24:1187-9.
23. Ibrahim HM, Ahmed TA, Lila AE, et al. (2010). Mucoadhesive controlled release microcapsules of indomethacin: optimization and stability study. J Microencapsul 27:377-86.
24. Jain S, Jain P, Umamaheshwari RB, Jain NK. (2003). Transfersomes - a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm 29:1013-26.
25. John C. (2000). Interpretation of infrared spectra: a practical approach. In: Meyers RA, ed. Encyclopedia of analytical chemistry. Chichester: John Wiley & Sons Ltd., 10815-37.
26. Khan MA, Sastry SV, Vaithiyalingam SR, et al. (2000). Captopril gastrointestinal therapeutic system coated with cellulose acetate pseudolatex: evaluation of main effects of several formulation variables. Int J Pharm 193:147-56.
27. Kumar A, Pathak K, Bali V. (2012). Ultra-adaptable nanovesicular systems: a carrier for systemic delivery of therapeutic agents. Drug Discov Today 17:1233-41.
28. Lewis GA, Mathieu D, Phan-Tan-Luu R. (1999). Pharmaceutical experimental design. New York: Marcel Dekker.
29. Liu T, Feng Y, Song D, Hu C. (2011). Selection of characteristic spectral bands for the analysis by the NIR correlation coefficient method. J Chin Pharm Sci 20:83-91.
30. Lynch TD, Laffey JG. (2006). Sildenafil for pulmonary hypertension in pregnancy? Anesthesiology 104:382.
31. Mahale NB, Thakkar PD, Mali RG, et al. (2012). Niosomes: novel sustained release nonionic stable vesicular systems - an overview. Adv Colloid Interface Sci 183-184:46-54.
32. Mahor S, Rawat A, Dubey PK, et al. (2007). Cationic transferosomes based topical genetic vaccine against hepatitis B. Int J Pharm 340:13-9.
33. Malakar J, Sen SO, Nayak AK, Sen KK. (2012). Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery. Saudi Pharm J 20:355-63.
34. McMahon CG, Stuckey BG, Andersen M, et al. (2005). Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation. J Sex Med 2:368-75.
35. Mitkari BV, Korde SA, Mahadik KR, Kokare CR. (2010). Formulation and evaluation of topical liposomal gel for fluconazole. Indian J Pharm Educ Res 44:324-32.
36. Nasr M, Mansour S, Mortada ND, Elshamy AA. (2008). Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J Microencapsul 25:499-512.
37. Nutan MT, Vaithiyalingam SR, Khan MA. (2007). Controlled release multiparticulate beads coated with starch acetate: material characterization, and identification of critical formulation and process variables. Pharm Dev Technol 12:307-20.
38. Patel H, Panchal MS, Shah S, Vadalia KR. (2012). Formulation and evaluation of transdermal gel of sildenafil citrate. Int J Pharm Res Allied Sci 1:103-18.
39. Patel R, Singh SK, Singh S, et al. (2009). Development and characterization of curcumin loaded transfersome for transdermal delivery. J Pharm Sci Res 1:71-80.
40. Paul A, Cevc G. (1995). Noninvasive administration of protein antigens: transdermal immunization with bovine serum albumin in transferosomes. Vaccine Res 4:145-64.
41. Planas ME, Gonzalez P, Rodriguez L, et al. (1992). Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes. Anesth Analg 75:615-21.
42. Pohle W, Guager DR, Fritzsche H, et al. (2001). Spectroscopic characterization of phosphocholin-headgroup model compounds. J Mol Struct 563-563:463-467.
43. Rajagopalan P, Mazzu A, Xia C, et al. (2003). Effect of high-fat breakfast and moderate-fat evening meal on pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction. J Clin Pharmacol 43:260-7.
44. Sastry BK, Narasimhan C, Reddy NK, Raju BS. (2004). Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study. J Am Coll Cardiol 43:1149-53.
45. Scognamiglio I, De Stefano D, Campani V, et al. (2013). Nanocarriers for topical administration of resveratrol: a comparative study. Int J Pharm 440:179-87.
46. Shan X, Chen L, Yuan Y, et al. (2010). Quantitative analysis of hemoglobin content in polymeric nanoparticles as blood substitutes using Fouriertransform infrared spectroscopy. J Mater Sci Mater Med 21:241-9.
47. Sharma A, Jain S, Modi M, et al. (2010). Recent advances in NDDS (Novel drug delivery systems) for delivery of Anti-HIV drugs. Res J Pharm Biol Chem Sci 1:78-88.
48. Shin HS, Bae SK, Lee MG. (2006). Pharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first pass effects. Int J Pharm 320:64-70.
49. Singh TP, Rohit M, Grover A, et al. (2006). A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension. Am Heart J 151:851.e1-5.
50. Sivakranth M, Althaf AS, Rajasekhar S. (2011). Formulation and evaluation of oral fast dissolving tablets of sildenafil citrarte. Int J Pharm Pharm Sci 3:112-21.
51. Sparsha N, Ravindra RK, Venkatesh P, et al. (2012). Development of new and rapid method for UV spectrophotometric determination of sildenafil in marketed formulations. Der Pharmacia Lettre 4:1756-9.
52. Taghizadeh SM, Bajgholi S. (2011). A new liposomal-drug-in-adhesive patch for transdermal delivery of sodium diclofenac. J Biomat Nanobiotech 2:576-81.
53. Trotta M, Peira E, Carlotti ME, Gallarate M. (2004). Deformable liposomes for dermal administration of methotrexate. Int J Pharm 270:119-25.
54. Trotta M, Peira E, Debernardi F, Gallarate M. (2002). Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int J Pharm 241:319-27.
55. Villanueva-Garcia D, Mota-Rojas D, Hernandez-Gonzalez R, et al. (2007). A systematic review of experimental and clinical studies of sildenafil citrate for intrauterine growth restriction and pre-term labour. J Obstet Gynaecol 27:255-9.
56. Walde P, Ichikawa S. (2001). Enzymes inside lipid vesicles: preparation, reactivity and applications. Biomol Eng 18:143-77.
57. Warnes CA. (2004). Pregnancy and pulmonary hypertension. Int J Cardiol 97:11-13.
58. Yang TZ, Wang XT, Yan XY, Zhang Q. (2002). Phospholipid deformable vesicles for buccal delivery of Insulin. Chem Pharm Bull 50:749-53.